Article ID Journal Published Year Pages File Type
3403473 Indian Journal of Tuberculosis 2016 6 Pages PDF
Abstract
BCG, the only available vaccine, though prevents against severe form of primary tuberculosis in paediatric population, failed to have its efficacy in pulmonary patients. Few candidates are in the pipeline undergoing clinical trial. An extensive research is needed to ensure their safety and efficacy before their acceptance as a TB vaccine to be incorporated in national immunization programmes.
Related Topics
Health Sciences Medicine and Dentistry Infectious Diseases
Authors
, , ,